Patent 7939511 was granted and assigned to Senju Pharmaceutical on May, 2011 by the United States Patent and Trademark Office.
The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.